In the latest quarter, 4 analysts provided ratings for Evolent Health (NYSE:EVH), showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Analysts have set 12-month price targets for Evolent Health, revealing an average target of $37.75, a high estimate of $45.00, and a low estimate of $31.00. Marking an increase of 7.86%, the current average surpasses the previous average price target of $35.00. Breaking Down Analyst Rating…